Cabaletta Bio Announces Pricing of Initial Public Offering
PHILADELPHIA, Oct. 25, 2019 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical stage biotechnology company focused on the […]
TSX News -
Helix BioPharma Corp. Announces Fiscal 2019 Year-End Results
RICHMOND HILL, Ontario, Oct. 25, 2019 (GLOBE NEWSWIRE) — Helix BioPharma Corp. (TSX: “HBP”), an immuno-oncology company developing drug candidates […]
Turnkey Enterprise LED Lighting and Controls Provider Orion Hosts Q2’20 Call on Wednesday, November 6th at 10:00 am ET
MANITOWOC, Wis., Oct. 25, 2019 (GLOBE NEWSWIRE) — Orion Energy Systems, Inc. (NASDAQ: OESX) (Orion Lighting), a provider of turnkey […]
Pacira to Report Third Quarter 2019 Financial Results on Thursday November 7, 2019
PARSIPPANY, N.J., Oct. 25, 2019 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its third […]
Ocugen to Host Conference Call on Friday, November 8 at 8:30 a.m. ET to Discuss Third Quarter Results and Recent Business Highlights
MALVERN, Pa., Oct. 25, 2019 (GLOBE NEWSWIRE) — Ocugen, Inc., (NASDAQ: OCGN), a clinical stage biopharmaceutical company focused on discovering, […]
MacroGenics Announces Initiation of Phase 2/3 MAHOGANY Study of Margetuximab in Gastric or Gastroesophageal Junction Cancer
Rockville, MD, Oct. 25, 2019 (GLOBE NEWSWIRE) —MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing […]
Acreage Holdings and GreenAcreage Announce $70+ Million Sale-Leaseback Transactions
NEW YORK, Oct. 25, 2019 (GLOBE NEWSWIRE) — Acreage Holdings, Inc. (“Acreage Holdings” or “Acreage”) (CSE: ACRG.U) (OTCQX: ACRGF) (FSE: […]
NuCana Announces FDA Clearance to Commence Phase III Study of Acelarin (NUC-1031) for the First-Line Treatment of Patients with Biliary Tract Cancer
Global NuTide:121 Study will Enroll up to 828 Patients and Compare Acelarin plus Cisplatin to Gemcitabine plus CisplatinPrimary Endpoints of […]
WisdomTree Announces Third Quarter 2019 Results
$4.2 million net income, or $10.6 million net income, as adjusted$0.02 diluted EPS for the quarter, $0.06 as adjustedDeclares $0.03 […]
Neovasc to Announce Third Quarter 2019 Financial Results on Thursday, November 7, 2019
VANCOUVER, Oct. 25, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Neovasc, Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), a leader in the [...]
